Bowel Cancer in the Family: Stage Beats Genes

If a parent or a sibling has had bowel cancer, the question you are almost certainly asking is: does bowel cancer run in families, and am I next? It is the right instinct to check, and the answer is yes, it can cluster in some families. But there is a second number that most people never look at, and it moves survival far more than your genes do. That number is the stage the cancer is caught at.

Here is the reframe this whole page is built around. Whether bowel cancer is hereditary in your family is worth establishing, and for a minority it genuinely matters. But once the disease is actually present, the single biggest lever on whether someone lives is how early it was found — and that is something screening and acting on symptoms can change, in a way you cannot change your DNA. The gradient in survival between the earliest and latest stage is wider than the difference family history makes.

So this article does two things in order. It tells you honestly what a family history of bowel cancer does and does not mean. Then it shows you the survival-by-stage figures for England, which are the numbers that ought to be driving your decisions.

The short answer: it can cluster, but stage moves survival

Bowel cancer is common, which is the first thing to hold onto. Because it is common, it turns up in a lot of families by chance alone, and a single relative with bowel cancer is far more often bad luck than a signal of an inherited fault. The fear that one diagnosis in the family means a gene marching down the generations is usually misplaced.

What is true is that a small proportion of bowel cancers arise in people who carry a specific inherited condition, and those families do face a genuinely raised risk that is worth identifying. Separating the common, sporadic case from the rare, inherited one is the job of your GP and, where the pattern warrants it, a genetics service. Most people who ask the question turn out to be in the first group.

And for everyone — inherited risk or not — the number that decides the most is the stage at diagnosis. That is the uncomfortable good news buried in this subject: the thing that matters most is also the thing you have some power over.

Is bowel cancer hereditary in the UK?

Mostly it is not. The large majority of bowel cancer in the UK is sporadic, meaning it arises from a combination of age, lifestyle and chance rather than from a fault passed down a family. This is why most people with one affected relative do not carry an inherited predisposition at all.

The exceptions are real and named. Lynch syndrome is the most common inherited cause, and it raises the lifetime risk of bowel and some other cancers significantly. Familial adenomatous polyposis is rarer and causes very large numbers of polyps from a young age. What flags these is a pattern rather than a single case: several close relatives affected, diagnoses at unusually young ages, or the same person having more than one related cancer. If that describes your family, it is worth raising specifically, because it can change how and when you are screened, and it may lead to a referral to clinical genetics.

Where an inherited fault is known to run in a family, a genetic test can sometimes place you firmly on one side of the line or the other, occasionally reached through cascade testing after a relative's result. A negative result in that situation is genuinely valuable, and it is one of the few results you are actually allowed to use to your advantage with an insurer, as we explain for anyone who has tested negative for a fault known to run in their family. The same protection that keeps an unfavourable result off your application also lets a favourable one work for you.

The number that actually matters: survival by stage

Now the figures that ought to be shaping your thinking. Survival from bowel cancer in England depends dramatically on the stage at which it is diagnosed — that is, how far it has spread by the time it is found. The spread between the best and worst stage is not a few percentage points; it is the difference between a strong likelihood of surviving and a slim one.

Caught at the earliest stage, when the cancer is still confined, the great majority of people — around nine in ten — survive at least five years. Found at the latest stage, once it has spread to distant parts of the body, only roughly one in ten do. Every stage in between sits on that slope. This is the bowel cancer survival by stage that the UK figures describe, and it is the reason clinicians press so hard on early detection: moving a diagnosis one stage earlier does more for a person's chances than almost anything else in the pathway.

Source: NHS England and the National Disease Registration Service, Cancer Survival in England, cancers diagnosed 2018 to 2022, published under the Open Government Licence v3.0.

Set that against family history and the point of this page comes into focus. Even for people with a raised inherited risk, the stage at which a cancer is found does more to determine the outcome than the family history did to cause it. The genes may load the dice on whether you get the disease; the stage decides much of what happens next. You can read the underlying survival statistics at Cancer Research UK, which presents the NDRS data by stage.

Why these figures are not your personal odds

It matters to be precise about what survival by stage does and does not tell you, because it is easy to misread in both directions. These are figures for people who have already been diagnosed. They answer the question "given that someone has bowel cancer found at this stage, how many survive five years" — not "what is my chance of getting bowel cancer" and not "what is my chance of dying of it from where I stand today, cancer-free".

Two consequences follow. First, the survival figures cannot be lifted straight onto yourself as a healthy person with a family history; your risk of ever being diagnosed is a separate question, and for most people it remains modest even with an affected relative. Second, comparisons of survival across time or across countries have to be read carefully, because catching cancers earlier — through screening — improves the survival statistics partly by finding disease sooner, quite apart from any change in treatment. The honest use of these numbers is as a powerful argument for early detection, not as a personal forecast.

What early detection actually asks of you

If stage is the number that matters, the practical question is how a cancer gets found early, and there are only two routes: screening and symptoms. Both are within reach.

NHS bowel cancer screening uses a home testing kit, the faecal immunochemical test or FIT, posted out to people within an age band. It looks for tiny traces of blood in a sample and flags who should be offered a colonoscopy. It is unglamorous and it works, because it finds disease in people who feel completely well. When a kit arrives, doing it is one of the highest-value few minutes available to you. Details of who is invited and when are on the NHS bowel cancer screening pages.

Between screening rounds, symptoms are the other route, and the ones worth knowing are blood in your stool, a persistent change in bowel habit, unexplained weight loss, and ongoing tummy pain. None of these means cancer — they have many innocent causes — but a change that persists for a few weeks is a reason to see a GP rather than wait for the next kit. Acting on a symptom early is exactly how a diagnosis moves down the stage slope towards the better end.

Family history of bowel cancer and when screening starts earlier

Standard screening is built for the general population. If bowel cancer has affected close relatives, particularly more than one or at young ages, the plan may be different for you: surveillance can start earlier and be done by colonoscopy rather than by the home kit. This is decided by your GP and, where warranted, a specialist, based on the pattern of who was affected and how young they were.

This is the practical payoff of taking the family history seriously without letting it frighten you into paralysis. The history's most useful role is not as a prophecy but as the thing that gets you screened sooner and more thoroughly, which pushes the stage at diagnosis — should it ever come to that — towards the survivable end. Gather the facts you can about which relatives were affected and at what age, and bring them to the appointment.

Where genetics meets your insurance

Two separate worries tend to arrive together here: the health worry and the insurance worry. On the insurance side, the position is more protective than most people expect, and it is worth knowing before you fill anything in.

A predictive genetic result — a Lynch or other inherited-cancer test that tells you about future risk before any disease — cannot be asked for or used on a UK life insurance application under the industry Code, in the same way that a positive BRCA result is never something a UK insurer can require. What insurers can still ask about is your own medical history and your family history in the ordinary sense. If you have actually had bowel cancer yourself, that is medical history rather than a gene result, and it is underwritten on its own terms — being past treatment is not the same as being risk-free to an underwriter, a point we make plainly in what "in remission" means to an underwriter. And if you are ever weighing whether an advanced diagnosis meets a policy's terminal-illness wording, that is a distinct test set out in when stage 4 cancer meets an insurer's definition.

For most readers of this page, though, the situation is simpler: a family history, no diagnosis of your own, and a wish to protect people who depend on you. Family history is a fair question on a form and answering it accurately is part of taking reasonable care, but it is rarely the barrier people fear. You can get life insurance quotes and let an FCA-authorised broker place your particular history sensibly, and the wider picture of how family history sits within an application is gathered in our guide to family history, inherited risk and the odds.

Scotland, Northern Ireland and where screening reaches

Bowel cancer screening is run separately by each UK nation, and the age band it covers is not identical everywhere. A home testing kit is offered to people aged 50 to 74 in Scotland and Wales, and the programme in England has been extending down towards 50 in phases, having historically started later. Northern Ireland runs its own programme on its own timetable. If you are close to the lower edge of the band, it is worth checking what applies where you live rather than assuming the age is the same across the UK.

The clinical response to a strong family history is broadly consistent across the four nations, but the referral routes into genetics and into earlier surveillance are organised nation by nation. As with screening, ask your GP how it works locally. Wherever you live, the underlying message does not change: the stage at which bowel cancer is found is the number that moves survival most, and screening and prompt attention to symptoms are how you influence it.

Frequently asked questions

Does bowel cancer run in families?

It can. Most bowel cancers are not inherited, but a minority occur in people carrying an inherited condition such as Lynch syndrome or familial adenomatous polyposis. Having one affected relative is common and does not by itself mean a faulty gene runs in the family, though it is worth telling your GP so they can judge whether the pattern warrants earlier screening.

Why does stage at diagnosis matter more than family history?

Survival in England differs enormously according to the stage at which bowel cancer is found. Caught early, the outlook is far better than when it is found after it has spread. That gradient is wider than the difference family history makes to the outcome once the disease is present, which is why screening and acting on symptoms count for so much.

When does NHS bowel cancer screening start?

A home testing kit is offered to people aged 50 to 74 in Scotland and Wales, and the English programme has been extending down to 50. If bowel cancer has affected close relatives, speak to your GP, because surveillance may start earlier and be done by colonoscopy rather than by kit. Check the age band that applies in your nation, as it is not identical everywhere.